Hyperfibrinolysis in cirrhosis.
D000328:Adult; D000510:Alpha-Globulins / Q000032:analysis; D000614:Aminocaproates / Q000627:therapeutic use; D001778:Blood Coagulation Disorders / Q000150:complications; D001779:Blood Coagulation Factors / Q000032:analysis; D001780:Blood Coagulation Tests; D004932:Esophageal and Gastric Varices / Q000150:complications; D005165:Factor V / Q000032:analysis; D005167:Factor VII / Q000032:analysis; D005170:Factor X / Q000032:analysis; D005260:Female; D005337:Fibrin / Q000378:metabolism; D005341:Fibrinolysin / Q000032:analysis; D005342:Fibrinolysis; D006471:Gastrointestinal Hemorrhage / Q000188:drug therapy / Q000209:etiology; D006801:Humans; D008103:Liver Cirrhosis / Q000150:complications*; D008259:Macroglobulins / Q000032:analysis; D008297:Male; D008875:Middle Aged; D010958:Plasminogen / Q000032:analysis; D011479:Protamines
D000510:Alpha-Globulins; D000614:Aminocaproates; D001779:Blood Coagulation Factors; D008259:Macroglobulins; D011479:Protamines; D005165:Factor V; D005167:Factor VII; D005170:Factor X; D005337:Fibrin; D010958:Plasminogen; D005341:Fibrinolysin